Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 227 results for "panacea biotec"

Market Growth at CAGR of 6.83% - Growing Demand Among Traveler...

/PRNewswire/ -- Research and Markets has announced the addition of the "Global Travel Vaccines Market 2016-2020" report to their offering. The global travel vaccines market to grow at a CAGR of 6.83% during the period 2016-2020. The report ... Wallstreet Online, 3 hours ago
[x]  

11 images for panacea biotec

Moneycontrol.com, 2 weeks ago
India Infoline, 2 weeks ago
India Infoline, 2 weeks ago
India Infoline, 2 weeks ago
Business Standard India, 2 months ago
Financial Express, 2 months ago
business-standard.com, 5 months ago
Financial Express, 5 months ago
India Infoline, 5 months ago
Financial Express, 5 months ago
Times of India

Life-saving drug for rare genetic disorder back on shelves soon

Mumbai: Patients suffering from Wilson's disease, a rare genetic disorder, can breathe easy as the life-saving drug, penicillamine, will be back on pharmacy shelves soon. The lone drug manufacturer, Panacea Biotec, plans to make available a 'limited ...
 Times of India2 days ago Life-saving drug scarce, patients left in the lurch  Times of India2 weeks ago Life-saving medicine D-Penicillamine unavailable, jeopardising lives of many  Times of India2 months ago

US$ 28 Bn Paediatric Vaccine Market to Grow at 14.4% CAGR Through 2026: Report

According to a new report published by Future Market Insights titled "Paediatric Vaccine Market: Global Industry Analysis & Opportunity Assessment, 2016 - 2026", in terms of revenue, the global paediatric vaccine market is expected to increase at ...
 PR Newswire3 days ago
[x]  

Travel Vaccines Market to Grow at 6.83% CAGR to 2020

Complete report on travel vaccines market spread across 60 pages, analysing 4 major companies and providing 64 data exhibits now available at http://www.reportsnreports.com/reports/769803-global-travel-vaccines-market-2016-2020.html . This ...
 PR Newswire1 week ago
[x]  

Pharmaceuticals Newsletter - November 21 to 25, 2016 [India Infoline News Service]

This week, Natco Pharma got USFDA approval for generic Budesonide Capsules for USA market, Suven Life Sciences Q2 FY17 PAT was at Rs 26.5 crore. IIFL presents a weekly snapshot of all the major happenings in the pharmaceuticals industry, nationally ...
 Pharmacy Choice1 week ago
Money Control

Panacea Biotec rises on receiving EIR report from USFDA for Baddi plant

SENSEX 25903.87 138.73 0.54% NIFTY 7966.20 37.10 0.47% Industry: Medical/Healthcare Company Panacea Biotec Ltd Panacea Biotec is currently trading at Rs 108.60, up by 0.65 points or 0.60% from its previous closing of Rs.
 Finalaya.com2 weeks ago Panacea Biotec shares climb 3% after inspection report  Business Standard2 weeks ago Panacea Biotec receives EIR from USFDA for Baddi facilities  Business Standard2 weeks ago Panacea Biotec Surges 7% As FDA Clears Solan Facility  NDTV2 weeks ago
[x]  

Panacea Biotec gains over 3% in two sessions

Panacea Biotec rose 1% to Rs 109 at 10:55 IST on BSE, extending yesterday's 2.32% rise triggered by the company receiving Establishment Inspection Report from US drug regulator for its facilities at Baddi in Himachal Pradesh.
 Business Standard2 weeks ago Panacea Biotec to hold board meeting  Business Standard1 month ago Panacea Biotec gains after announcing shortage of Cilamin 250 Capsule  Business Standard2 months ago

Panacea net loss declines to Rs. 11.84 cr in Q2

Panacea Biotec has cut down its net loss to Rs. 11.84 crore during the second quarter ended September 2016 from Rs. 17.90 crore in the corresponding period of last year despite lower net sales. Its net sales declined by 18.2 per cent to Rs. 131.56 ...
 PharmaBiz3 weeks ago Panacea Biotec reports standalone net loss of Rs 11.84 crore in the September 2016 quarter  Business Standard4 weeks ago

Panacea Biotec heads north after receiving EIR from US drug regulator

Panacea Biotec rose 1.61% to Rs 107.20 at 12:16 IST on BSE after the firm received Establishment Inspection Report from USFDA for its oncology parenteral and oral solids dosage formulation facilities at Baddi in Himachal Pradesh.
 Business Standard2 weeks ago

Panacea Biotec recieves EIR for its company's Oncology Parenteral and Oral Solids Dosage formulations facility in Baddi

This page uses frames, but your browser doesn't
 Capital Market2 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less